Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Eluxadoline 100 mg
DRUG
2 trials
Sponsors
University of North Carolina, Chapel Hill
, Temple University
Conditions
Accidental Bowel Leakage
Anal Incontinence
Diabetes
Diabetic Diarrhea
Diarrhea
Fecal Incontinence
Urge Incontinence
Phase 2
Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence
Withdrawn
NCT03489265
University of North Carolina, Chapel Hill
Accidental Bowel Leakage, Anal Incontinence, Diarrhea +2
Start: 2019-04-30
End: 2020-03-31
Updated: 2019-07-25
Investigation of Eluxadoline for Diabetic Diarrhea
Withdrawn
NCT04313088
Temple University
Diabetes, Diabetic Diarrhea, Diarrhea
Start: 2022-07-01
End: 2024-12-31
Updated: 2023-05-06